3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
45
Carcinoma, Hepatocellular
13
Osteosarcoma
8
Neoplasms
8
Sarcoma
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Colorectal Neoplasms
7
Sarcoma, Ewing
6
Neuroendocrine Tumors
6
Kidney Neoplasms
6
Clear-cell metastatic renal cell carcinoma
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Transitional Cell
4
Carcinoma, Medullary
4
Carcinoma
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Thyroid Neoplasms
3
Ovarian Neoplasms
3
Melanoma
3
Endometrial Neoplasms
3
Adrenocortical Carcinoma
3
Wilms Tumor
2
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Stomach Neoplasms
2
Interventions
fludarabine
1
aldesleukin
1
Cyclophosphamide
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenosquamous
×
cabozantinib
×
1 year
×
Clear all
No trials found.